hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial
Stem Cells Translational Medicine · 22.04.2025 · 14 (4)
DOI: 10.1093/stcltm/szaf011 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 15.05.2025. Verfasst von Zhaojuan Hou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine, Xiangya Hospital of Central South University, Changsha 410000, People's Republic of China. Hauptthemen laut MEDLINE: Endometrium, Gynatresia, Mesenchymal Stem Cells, Tissue Scaffolds. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
In this single-center, double-blinded, randomized controlled trial, we investigated whether human umbilical cord-derived mesenchymal stromal cells loaded collagen scaffolds (hUC-MSC/CS) could improve the cumulative live-birth rate (cLBR) in infertile women with refractory thin endometrium (RTE). We randomly assigned 25 subfertile women with RTE, in a 1:1 ratio, to receive hysteroscopic adhesiolysis and plowing plus either hUC-MSC/CS or saline/CS (control) for intrauterine implantation. Uterine fluid was collected on the embryo transfer day for RNA-sequencing to explore the potential mechanisms by which hUC-MSCs exert their effects. The primary outcome was the cLBR. Live births occurred in 3 out of 11 women in the hUC-MSC/CS group and in 1 out of 13 women in the control group (27.3% vs 7.7%; relative risk [RR], 3.55; 95% confidence interval [CI], 0.43 to 29.42; P = .30). The cumulative frequencies of clinical pregnancy were 5/11 and 1/13 in the hUC-MSC/CS group and control group, respectively (45.5% vs. 7.7%; RR, 5.91; 95% CI, 0.81-43.28; P = .06). Two of 11 participants developed urticaria in the hUC-MSC/CS group. Enrichment analysis showed that T-cell activation had the largest proportion in the biological process category. Kyoto Encyclopedia of Genes and Genomes pathway analysis showed that most genes were related to cytokine-cytokine receptor interaction. In conclusion, there was a non-significant trend toward a higher cLBR with hUC-MSC/CS compared to controls, potentially through the cytokine-cytokine receptor interaction pathway. hUC-MSCs appeared to be relatively safe in a 1-year follow-up. Therefore, this novel therapy can be proposed to patients with RTE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine, Xiangya Hospital of Central South University, Changsha 410000, People's Republic of China.
- the Clinical Research Center For Women's Reproductive Health in Hunan Province, Changsha 410000, People's Republic of China.
- the Department of Gynecology, Third Xiangya Hospital of Central South University, Changsha 410000, People's Republic of China.
- the Center for Clinical Trial, Xiangya Hospital of Central South University, Changsha 410000, People's Republic of China.
- the Institute of Geriatrics & National Clinical Research Center of Geriatrics Disease, the Second Medical Center, Chinese PLA General Hospital, Beijing 100000, People's Republic of China.
- Department of Hepatobiliary & Pancreatic Surgery, the Third Bethune Hospital of JiLin University, Changchun 130000, People's Republic of China.
ORCID-Profile: Dabao Xu, Jing Zhao, Bin Xu, Yanping Li
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Hou, Z., Yang, T., Xu, D., Fu, J., Tang, H., Zhao, J., Zhang, Q., Chen, J., Qin, Q., Li, W., Chen, H., Li, H., Guo, L., Xu, B., & Li, Y. (2025). hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial. Stem Cells Translational Medicine, 14(4). https://doi.org/10.1093/stcltm/szaf011
Vancouver
Hou Z, Yang T, Xu D, Fu J, Tang H, Zhao J, et al. hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial. Stem Cells Translational Medicine. 2025;14(4). doi:10.1093/stcltm/szaf011
BibTeX
@article{Hou2025,
author = {Hou, Zhaojuan and Yang, Tianli and Xu, Dabao and Fu, Jing and Tang, Hongying and Zhao, Jing and Zhang, Qiong and Chen, Jingjing and Qin, Qun and Li, Waixing and Chen, Haixu and Li, Hui and Guo, Lei and Xu, Bin and Li, Yanping},
title = {hUC-MSCs loaded collagen scaffold for refractory thin endometrium caused by Asherman syndrome: a double-blind randomized controlled trial},
journal = {Stem Cells Translational Medicine},
year = {2025},
volume = {14},
number = {4},
doi = {10.1093/stcltm/szaf011}
}
EUVIMED